Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy

Published 2013 View Full Article

Authors

Keywords

Neutropenia, Febrile neutropenia, Breast cancer, Recombinant granulocyte-colony stimulating factor, Lipegfilgrastim, Pegfilgrastim

Journal

BMC CANCER

Volume 13, Issue 1, Pages -

Publisher

Springer Nature

Online

2013-08-14

DOI

10.1186/1471-2407-13-386

References

View 3 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.